References
- GianniniGCabriWFattorussoCRodriquezMHistone deacetylase inhibitors in the treatment of cancer: overview and perspectivesFuture Med Chem201241439146022857533
- ThalerFCurrent trends in the development of histone deacetylase inhibitors: a review of recent patent applicationsPharm Pat Anal20121759024236715
- GryderBESodjiQHOyelereAKTargeted cancer therapy: giving histone deacetylase inhibitors all they need to succeedFuture Med Chem2012450552422416777
- XuWSParmigianiRBMarksPAHistone deacetylase inhibitors: molecular mechanisms of actionOncogene2007265541555217694093
- CeaMCagnettaAGobbiMNew insights into the treatment of multiple myeloma with histone deacetylase inhibitorsCurr Pharm Des20131973474423016853
- ZhangLLiMFengJFangHXuWDiscovery of a novel histone deacetylase 8 inhibitor by virtual screeningMed Chem Res201221152156
- ZhangLWangXLiXXuWDiscovery of a series of small molecules as potent histone deacetylase inhibitorsJ Enzyme Inhib Med Chem20142933333723534931
- ZhangLZhangYChouCJHistone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activitiesChemMedChem2014963864824227760
- ErtlPRohdeBSelzerPFast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport propertiesJ Med Chem2000433714371711020286
- LiXInksESLiXDiscovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activityJ Med Chem2014573324334124694055
- LiXHouJLiXDevelopment of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activityEur J Med Chem20158962863725462271
- DuanWLiJInksESDesign, synthesis and antitumor evaluation of novel histone deacetylase (HDAC) inhibitors equipped with phenylsulfonylfuroxan module as nitric oxide (NO) donorJ Med Chem2015894325433825906087